Trials / Completed
CompletedNCT02701582
Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized controlled trial to determine if using FloTrac/EV1000 system in neurosurgical patients undergoing craniotomies for aneurysm repair or tumor resection complicated by cerebral edema, or complex spinal surgery including multi-level scoliosis correction, is a more effective way of monitoring fluid.
Detailed description
We hypothesize that the ability to assess volume status and fluid responsiveness with information gained from Edwards FloTrac/EV1000 system coupled with a goal-directed therapy fluid management algorithm can make a difference in patient outcomes. Our specific aims are: * Demonstrate goal-directed therapy (GDT) in fluid management improves peri-operative fluid balance * Demonstrate GDT improves pulmonary function and organ oxygenation * Demonstrate GDT reduces necessary therapeutic interventions in the peri- operative period * Demonstrate GDT reduces hypotensive episodes in the peri-operative period Outcomes We will study the consequences of goal-directed fluid therapy that employs use of dynamic indicators seen on FloTrac/EV1000 system by measuring the following: * Pulmonary status * Time to extubation * Alveolar-arterial (A-a) gradient of oxygen * Requirements for supplemental oxygen * Organ oxygenation * Serum lactate * Arterial blood gas values (pH, HCO3, CO2, O2) * Length of stay (LOS) * In hospital, defined as time from operation start to eligibility for discharge from hospital according to surgeon in accordance with pre-define criteria * In ICU/PACU, defined as time from operation end to eligibility for discharge from intensive care according to attending intensivist in accordance with pre- define criteria * Fluid Balance * Inputs and outputs (I/Os) of all measurable fluids (i.e. blood, crystalloid, colloid) in peri-operative period, through and including duration of intensive care or the next 24-48 hours after completion of surgery * Drugs administered for fluid management (i.e. mannitol, vasopressors) * Pre-operative and post-operative body weights and twice-daily weights via bed weights * Hypotension * Number, duration and severity (i.e. minimum blood pressure) of hypotensive episode, defined as MAP \<65
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Phenylephrine | if Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \< 13 and Cardiac Index is \>=2.2 Phenylephrine is administered |
| DRUG | Epinephrine | if Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \< 13 and Cardiac Index is \< 2.2 Epinephrine is administered |
| OTHER | Albumin | if Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered. |
| OTHER | Voluven | if Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered. |
| OTHER | Normal Saline | if Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered. |
| OTHER | Packed Red Blood Cells | if Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered. |
| DEVICE | FloTrac Monitor | FloTrac monitor is connected for all patients, but only visible to the anesthesiologist for half. Based on a decision tree and the data from monitor, choices of interventions are used. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-01-01
- Completion
- 2016-09-01
- First posted
- 2016-03-08
- Last updated
- 2019-08-28
- Results posted
- 2019-08-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02701582. Inclusion in this directory is not an endorsement.